Section 10.5: Psychopharmacology and Medication Safety

Why Psychopharmacology Is Its Own Block

Nursing Practice V explicitly lists psychopharmacology as a competency because medication management is central to psychiatric nursing. Items test priority adverse effects, therapeutic monitoring, and client teaching rather than pharmacology trivia. Because several psychiatric drugs have narrow therapeutic windows or emergency toxicities, this content overlaps with safe-medication administration and prioritization.

Antipsychotics (Neuroleptics)

Antipsychotics treat schizophrenia and other psychoses by blocking dopamine.

• Typical (first-generation): haloperidol, chlorpromazine—effective for positive symptoms but higher risk of extrapyramidal symptoms (EPS).
• Atypical (second-generation): risperidone, olanzapine, clozapine, quetiapine—broader symptom coverage but metabolic effects (weight gain, hyperglycemia).

Extrapyramidal symptoms are the classic exam focus: acute dystonia (muscle spasms, torticollis, oculogyric crisis), akathisia (motor restlessness), pseudoparkinsonism (tremor, rigidity, shuffling gait), and tardive dyskinesia (late, often irreversible involuntary movements of the face and tongue). Anticholinergics such as benztropine treat acute EPS.

Neuroleptic Malignant Syndrome (NMS) is a rare but life-threatening emergency: sudden high fever, severe muscle rigidity, altered mental status, and autonomic instability. The nurse must stop the antipsychotic immediately, support cooling and hydration, and notify the provider. Clozapine additionally requires monitoring for agranulocytosis via regular WBC counts.

Antidepressants

Two high-yield safety points: antidepressants take weeks to work, so monitor for increased suicide risk as energy returns before mood lifts; and serotonin syndrome (agitation, hyperthermia, tremor, hyperreflexia) can occur when serotonergic drugs are combined.

Mood Stabilizers

Lithium is the prototype for bipolar disorder and a perennial exam favorite because of its narrow therapeutic range of 0.6–1.2 mEq/L. Levels above 1.5 mEq/L cause toxicity (nausea, vomiting, diarrhea, coarse tremor, confusion, seizures at higher levels). Teaching essentials:

• Maintain consistent fluid and sodium intake—dehydration or low sodium raises lithium levels dangerously.
• Report early toxicity signs and attend routine serum lithium level checks.
• Anticonvulsants (valproate, carbamazepine) are alternative mood stabilizers requiring their own lab monitoring.

Antianxiety Agents

Benzodiazepines (lorazepam, diazepam, alprazolam) enhance GABA for rapid anxiety relief and are used short-term because of dependence and tolerance risk. Warn clients against alcohol (additive CNS depression) and abrupt discontinuation (withdrawal seizures). Buspirone is a non-benzodiazepine option with no dependence risk but a delayed onset of 1–2 weeks.

The Nurse's Role

Across all classes, the priority nursing actions are the same: teach the expected onset and adverse effects, stress adherence (stopping antipsychotics or antidepressants abruptly risks relapse or withdrawal), monitor the relevant labs, and recognize the emergencies—NMS, serotonin syndrome, lithium toxicity, and hypertensive crisis—fast enough to intervene.

Serotonin Syndrome vs. NMS

Examinees must distinguish two emergencies that look similar. Serotonin syndrome arises from excess serotonergic activity - often when an SSRI is combined with another serotonergic drug (a second antidepressant, tramadol, or an MAOI) - and presents with agitation, hyperthermia, diaphoresis, tremor, and hyperreflexia/clonus that develop over hours. Neuroleptic malignant syndrome follows antipsychotics and presents with lead-pipe rigidity, high fever, and hyporeflexia over days. Both require stopping the offending drug and supportive cooling, but the drug class and reflex pattern differentiate them.

Client and Family Teaching

Adherence is the single biggest determinant of psychiatric outcomes, so teaching is heavily tested:

• Set realistic expectations: antidepressants and buspirone take 2-4 weeks for full effect; clients who expect immediate relief often stop early.
• Monitor suicide risk: as an antidepressant restores energy before it lifts mood, the client may gain the drive to act on suicidal thoughts - supervise closely in the first weeks.
• Never stop abruptly: discontinuing antipsychotics risks relapse; stopping benzodiazepines abruptly risks withdrawal seizures; SSRIs can cause a discontinuation syndrome.
• Diet and interaction warnings: MAOI clients must avoid tyramine-rich foods to prevent hypertensive crisis; lithium clients keep fluid and salt intake steady; all clients avoid alcohol.

Special Monitoring

Safe Administration in Context

Psychiatric medications intersect with prioritization and delegation: a nurse cannot delegate the assessment of a client's response to a new antipsychotic to unlicensed staff, and must personally verify that a potentially suicidal client actually swallows oral doses (checking for cheeking). Because many of these clients also have physical comorbidities, the nurse integrates psychopharmacology with the medical-surgical safety principles taught earlier - reconciling drug lists, watching for interactions, and documenting both therapeutic and adverse responses.